Miruvor
Sign up
Long COVID Outcome unclear

Long COVID unchanged after Paxlovid trial; chest pain and kidney injury resolved

Condition
Long COVID
At worst
Not stated
Ill for
Not stated
Last post
Jan 2024
In their words
  • Condition: Long COVIDI did the 15-day Paxlovid vs placebo clinical trial with Stanford last year. In context ↗
Read from 2 of their posts and comments; links to the 2 this page draws on

Request to remove this story

Summary

Flint 78083, a long COVID patient, took part in a 15-day Paxlovid versus placebo clinical trial with Stanford in 2023. On day 8 they developed constant chest pain and intermittent flank pain, and labs on day 15 showed acute kidney injury. These symptoms resolved around day 20/21 after they stopped taking it on day 15. They noticed no changes in their long COVID symptoms from the trial.

Ask Miruvor AI

Asking aboutFlint 78083’s story

What they tried

Also tried

Their words about each treatment
  • Paxlovid · WorseI did the 15-day Paxlovid vs placebo clinical trial with Stanford last year. ... Didn't notice any changes.

Their path

They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.

WhenWhat happened
2023 (Day 8 of Paxlovid trial)developed constant chest pain and intermittent flank painI started having constant chest pain and intermittent flank pain on Day 8. In context ↗
2023 (Day 15 of Paxlovid trial)labs showed AKIlabs drawn on Day 15 showed AKI In context ↗
2023 (Day 20/21 after stopping Paxlovid)chest pain, flank pain, and AKI resolvedChest pain, flank pain, and AKI resolved around Day 20/21 after I stopped taking it on Day 15. In context ↗
2024-01-11no change in long COVID symptoms from Paxlovid trialDidn't notice any changes. In context ↗

Adverse events

Symptoms mentioned

Their words about their symptoms

Ask Miruvor AI

Asking aboutFlint 78083’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime